Detalhe da pesquisa
1.
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
N Engl J Med
; 382(2): 140-151, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914241
2.
Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.
Br J Haematol
; 196(5): 1262-1270, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34738634
3.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438802
4.
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Clin Exp Rheumatol
; 40(7): 1336-1342, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579092
5.
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.
Br J Haematol
; 194(2): 336-343, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34151423
6.
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Haematologica
; 106(5): 1414-1422, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626866
7.
Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies.
Eur J Haematol
; 106(5): 616-626, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340150
8.
Small Private Online Course in Teaching Oncology-Feedback After 1 Year: What Lessons?
J Cancer Educ
; 36(1): 65-71, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410821
9.
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 105(3): 632-639, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171638
10.
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.
Haematologica
; 104(8): 1565-1571, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733271
11.
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Br J Haematol
; 181(3): 350-359, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611196
12.
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.
Blood
; 127(6): 749-60, 2016 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626993
13.
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
Eur J Haematol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719933
14.
Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).
Eur J Haematol
; 100(5): 412-418, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360249
15.
Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
Am J Hematol
; 92(6): 493-500, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240787
16.
Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study.
Am J Hematol
; 97(2): E40-E44, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779031
17.
A randomized phase II trial of azacitidine +/- epoetin-ß in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents.
Haematologica
; 101(8): 918-25, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27229713
18.
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study.
Lancet Oncol
; 16(15): 1506-1514, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26404501
19.
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.
Emerg Infect Dis
; 21(8): 1466-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26197210
20.
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.
Br J Haematol
; 168(3): 361-70, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25272332